524768 EMMESSA

Emmessar Biotech & Nutrition Share Price

 

 

Start SIP in EMMESSA

Start SIP
Emmessar Biotech & Nutrition live price: ₹25.74. It opened at ₹24 vs previous close ₹24; intraday high/low: ₹27/₹23. The 50 & 200 DMA stand at ₹25.99/₹29.67.

Emmessar Biotech & Nutrition Performance

  • Today's Low
  • ₹23
  • Today's High
  • ₹27
  • 52 Week Low
  • ₹18
  • 52 Week High
  • ₹43
  • Open Price₹24
  • Previous Close₹24
  • Volume948
  • 50 DMA₹25.99
  • 100 DMA₹27.54
  • 200 DMA₹29.67

Investment Returns

  • Over 1 Month -0.66%
  • Over 3 Month -12.75%
  • Over 6 Month -22.84%
  • Over 1 Year -15.3%

Smart Investing Starts Here Start SIP with Emmessar Biotech & Nutrition for Steady Growth!

Invest Now

Emmessar Biotech & Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 38.6
  • PEG Ratio
  • -0.7
  • Market Cap Cr
  • 13
  • P/B Ratio
  • 1.6
  • Average True Range
  • 2.51
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.78
  • RSI
  • 46.66
  • MFI
  • 76.84

Emmessar Biotech & Nutrition Financials

Emmessar Biotech & Nutrition Technicals

EMA & SMA

Current Price
₹25.74
+ 1.72 (7.16%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹24.54
  • 50 Day
  • ₹25.99
  • 100 Day
  • ₹27.54
  • 200 Day
  • ₹29.67

Resistance and Support

24.69 Pivot Speed
  • R3 31.18
  • R2 29.24
  • R1 26.63
  • S1 22.08
  • S2 20.14
  • S3 17.53

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emmessar Biot.& Nut. has an operating revenue of Rs. 0.37 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 157% is great, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 44 which is a POOR score indicating inconsistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 37 indicates it belongs to a strong industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Emmessar Biotech & Nutrition Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-07 Quarterly Results
2025-04-24 Audited Results
2025-02-06 Quarterly Results

Emmessar Biotech & Nutrition F&O

Emmessar Biotech & Nutrition Shareholding Pattern

59.53%
0.05%
0.14%
38.09%
2.19%

Emmessar Biotech & Nutrition FAQs

Emmessar Biotech & Nutrition share price is ₹25 As on 30 March, 2026 | 14:41

The Market Cap of Emmessar Biotech & Nutrition is ₹12.9 Cr As on 30 March, 2026 | 14:41

The P/E ratio of Emmessar Biotech & Nutrition is 38.6 As on 30 March, 2026 | 14:41

The PB ratio of Emmessar Biotech & Nutrition is 1.6 As on 30 March, 2026 | 14:41

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23